Not applicableEnrolling By InvitationNCT07319299What this trial is testingSTOP HCC-GAAD-APAC-ThailandWho this might be right forHepatecellular CarcinomaCirrhosisHBV Infection Mahidol University 2,100
Not applicableNot Yet RecruitingNCT07482670What this trial is testingEfficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases (CAPLocal) : A Multicentre, Single-Arm,Prospective Cohort StudyWho this might be right forHepatecellular Carcinoma Xiangya Hospital of Central South University 32
Testing effectiveness (Phase 2)Looking for participantsNCT07327788What this trial is testingQL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTTWho this might be right forHepatecellular CarcinomaRALOX-HAIC(Hepatic Arterial Infusion Chemotherapy With Raltitrexed and OxaliplatinBevacizumab+3 more Nanfang Hospital, Southern Medical University 38
Early research (Phase 1)Not Yet RecruitingNCT07436988What this trial is testingAffordable Made-in-India Microspheres for Liver Cancer TherapyWho this might be right forHepatecellular Carcinoma Post Graduate Institute of Medical Education and Research, Chandigarh 18
Not applicableStudy completedNCT07277192What this trial is testingHAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and SurvivalWho this might be right forHepatecellular CarcinomaLiver InjuryHAIC(Hepatic Artery Infusion Chemotherapy)+1 more Nanfang Hospital, Southern Medical University 562
Early research (Phase 1)Looking for participantsNCT07705334What this trial is testingSHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsTriple Negative Breast Cancer (TNBC)HR+ Breast Cancer+8 more SHY Therapeutics 30
Not applicableStudy completedNCT02056041What this trial is testingSelection Criteria for Safe Hepatectomy for Hepatocellular CarcinomaWho this might be right forHepatectomyHepatecellular CarcinomaCirrhosis University of Milan 336
Not applicableLooking for participantsNCT07062380What this trial is testingAI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)Who this might be right forHepatecellular CarcinomaHepatectomy Tongji Hospital 353